Bulking agents for minimally invasive correction of stress urinary incontinence in women

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

作者简介

Elena Rusina

Ott Research Institute of Obstetrics, Gynecology and Reproductology

编辑信件的主要联系方式.
Email: pismo_rusina@mail.ru
ORCID iD: 0000-0002-8744-678X

MD, Dr. Sci. (Med.)

俄罗斯联邦, 3 Mendeleevskaya Line, Saint Petersburg, 199034

Maria Zhevlakova

Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: gynecologist.spb@mail.ru

Postgraduate student of the Department of Gynecology and Endocrinology

俄罗斯联邦, 3 Mendeleevskaya Line, Saint Petersburg, 199034

参考

  1. Almousa S, Bandin van Loon A. The prevalence of urinary incontinence in nulliparous adolescent and middle-aged women and the associated risk factors: A systematic review. Maturitas. 2018;107:78–83. doi: 10.1016/j.maturitas.2017.10.003
  2. Rusina EI, Bezhenar VF, Ivashchenko TE, et al. The specific features of MMP1, MMP3, and PAI1 gene polymorphisms in patients with pelvic organ prolapse and stress urinary incontinence. Obstetrics and Gynecology 2014;(9):63–68. (In Russ.)
  3. Apolihina IA, Saidova IS. Stress urinary incontinence. Obstetrics and Gynecology. 2019(3 Suppl):20–25. (In Russ.)
  4. Abrams P, Smith AP, Cotterill N. The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA. BJU Int. 2015;115(1):143–152. doi: 10.1111/bju.12852
  5. Kira KE, Bezhenar VF, Prokhorova VS. Urethrovesical segment ultrasound for the efficacy evaluation of surgical treatment of stress urinary incontinence. Journal of Obstetrics and Women’s Diseases. 2021;69(6):43–48. (In Russ.). doi: 10.17816/JOWD69643-48
  6. Zheleznyakova IA. Optimizaciya lecheniya stressovogo nederzhaniya mochi u zhenshchin s pomoshch’yu metoda ekstrakorporal’noj magnitnoj stimulyacii. [dissertation abstract]. Moscow; 2011. (In Russ.). [cited 2021 July 1]. Available from: https://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst/readhttps://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst/read
  7. McGuire EJ. Pathophysiology of stress urinary incontinence. Rev Urol. 2004;6 Suppl 5(Suppl 5):S11–S17.
  8. Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database of Systematic Reviews. 2017;2017;7(7):1–67. doi: 10.1002/14651858.CD003881.pub4
  9. Li H, Westney OL. Injection of urethral bulking agents. Urol Clin North Am. 2019;46(1):1–15. doi: 10.1016/j.ucl.2018.08.012
  10. Linder BJ, Elliott DS. Synthetic midurethral slings: roles, outcomes, and complications. Urologic Clinics of North America. 2019;46(1):17–30. doi: 10.1016/j.ucl.2018.08.013
  11. Capobianco G, Saderi L, Dessole F, et al. Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis. Maturitas. 2020;133:13–31. doi: 10.1016/j.maturitas.2019.12.007
  12. Martin K, Emil S, Bernard C, et al. Dextranomer hyaluronic acid copolymer effects on gastroesophageal junction. J Pediatr Gastroenterol Nutr. 2014;58(5):593–597. doi: 10.1097/MPG.0000000000000259
  13. Brown JE, Gulka CP, Giordano JEM, et al. Injectable silk protein microparticle-based fillers: A novel material for potential use in glottic insufficiency. J Voice. 2019;33(5):773–780. doi: 10.1016/j.jvoice.2018.01.017
  14. Fallacara A, Manfredini S, Durini E, Vertuani S. Hyaluronic acid fillers in soft tissue regeneration. Facial Plast Surg. 2017;33(1):87–96. Corrected and republished from: Facial Plast Surg. 2017;33(2):244. doi: 10.1055/s-0036-1597685
  15. Parker R. The paraffin injection treatment of Gersuny with a report of cases. JAMA. 1902;XXXVIII(16):1000–1003. doi: 10.1001/jama.1902.62480160022001d
  16. Murless B. The injection treatment of stress incontinence. Br J Obstet Gynaecol. 1938;45(1):521–524. doi: 10.1111/j.1471-0528.1938.tb12430.x
  17. Chaliha C, Williams G. Periurethral injection therapy for the treatment of urinary incontinence. Br J Urol. 1995;76(2):151–155. doi: 10.1111/j.1464-410x.1995.tb07663.x
  18. Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol. 2001;165(1):153–158. doi: 10.1097/00005392-200101000-00037
  19. Currie I, Drutz HP, Deck J, Oxorn D. Adipose tissue and lipid droplet embolism following periurethral injection of autologous fat: case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(6):377–380. doi: 10.1007/BF02765599
  20. Sokol ER, Karram MM, Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study. J Urol. 2014;192(3):843–849. doi: 10.1016/j.juro.2014.03.109
  21. Gorton E, Stanton S, Monga A, et al. Periurethral collagen injection: a long-term follow-up study. BJU Int. 1999;84(9):966–971. doi: 10.1046/j.1464-410x.1999.00321.x
  22. Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(8):869–873. doi: 10.1007/s00192-006-0251-2
  23. Chapple C, Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence. Res Rep Urol. 2019;11:299–310. doi: 10.2147/RRU.S220216
  24. Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J. 2013;24(1):27–36. doi: 10.1007/s00192-012-1825-9
  25. Serati M, Soligo M, Braga A, et al. Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow-up. BJU Int. 2019;123(2):353–359. doi: 10.1111/bju.14550
  26. Carroll TF, Christie A, Foreman M, et al. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency. Int Braz J Urol. 2019;45(5):989–998. doi: 10.1590/S1677-5538.IBJU.2019.0070
  27. Bennett AT, Lukacz ES. Two cases of suspected rejection of polydimethylsiloxane urethral bulking agent. Female Pelvic Med Reconstr Surg. 2017;23(3):e10–e11. doi: 10.1097/SPV.0000000000000367
  28. Rodríguez D, Jaffer A, Hilmy M, Zimmern P. Bladder neck and urethral erosions after Macroplastique injections. Low Urin Tract Symptoms. 2021;13(1):93–97. doi: 10.1111/luts.12337
  29. Capobianco G, Azzena A, Saderi L, et al. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2018;29(9):1239–1247. doi: 10.1007/s00192-018-3703-6
  30. de Vries AM, van Breda HMK, Fernandes JG, et al. Para-urethral injections with Urolastic® for treatment of female stress urinary incontinence: Subjective improvement and safety. Urol Int. 2017;99(1):91–97. doi: 10.1159/000452450
  31. Christensen LH, Nielsen JB, Mouritsen L, et al. Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig. Dermatol Surg. 2008;34(Suppl 1):S68–S77. doi: 10.1111/j.1524-4725.2008.34246.x
  32. Kasi AD, Pergialiotis V, Perrea DN, et al. Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27(3):367–375. doi: 10.1007/s00192-015-2781-y
  33. Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40(1):502–508. doi: 10.1002/nau.24589
  34. Sigaeva NN, Kolesov SV, Nazarov PV, Vildanova RR. Himicheskaya modifikatciya gialuronovoy kisloty i ee primenenie in meditsine. Vestnik Bashkirskogo Universiteta. 2012;17(3):1220–1241. (In Russ.)
  35. Zhu Y, Hu J, Yu T, et al. High molecular weight hyaluronic acid inhibits fibrosis of endometrium. Med Sci Monit. 2016;22:3438–3445. doi: 10.12659/msm.896028
  36. Semenova EF, Polyakova AA, Agabalaeva KO, et al. Development of some stages of technology of microbial synthesis. Belgorod State University Scientific Bulletin Natural Sciences. 2018;42(3):297–307. doi: 10.18413/2075-4671-2018-42-3-297-307
  37. Chapple CR, Haab F, Cervigni M, et al. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol. 2005;48(3):488–494. doi: 10.1016/j.eururo.2005.05.007
  38. Apolikhina IA, Saidova AS, Makhmedzhanova FN. Use of volume-forming drugs to treat female stress urinary incontinence. Obstetrics and gynecology. 2011;(7–1):21–24. (In Russ.)
  39. Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009;74(4):771–775. doi: 10.1016/j.urology.2009.05.034
  40. Elzayat EA, Karsenty G, Bismar TA, Corcos J. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(2):247–252. doi: 10.1007/s00192-007-0414-9
  41. Burkhard FC, Bosch JLHR, Cruz F, et al. EAU Guidelines on Urinary Incontinence in Adults. European Association of Urology. 2020. [cited 2021 July 1]. Available from: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urinary-Incontinence-2020.pdf
  42. Zakirova GSh, Gubanova EI, Gladko VV, et al. A randomized study of the safety and effectiveness of products based on stabilized hyaluronic acid for the correction of involutional changes in face and neck. Russian Journal of Skin and Venereal Diseases. 2018;21(1):53–60. (In Russ.). doi: 10.18821/1560-9588-2018-21-1-51-53-60
  43. Watad A, Quaresma M, Bragazzi NL, et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol. 2018;37(2):483–493. doi: 10.1007/s10067-017-3748-9
  44. Apolikhina IA, Sokolova AV, Saidova AC, Gorbunova EA. Autologous platelet-rich plasma combined with hyaluronic acid is a new method of minimally invasive treatment of stress urinary incontinence in women. Medicinskij Sovet. 2018(13):16–20 (In Russ.). doi: 10.21518/2079-701X-2018-13-16-20
  45. Rusina EI. Effectivnost’ parauretralnogo vvedeniya gialuronovoy kisloti pri stressovom nederzanii mochi u zhenshchin. In: International Congress “Operative Gynecology – Advanced Technologies” Overlook – 24-28 October 2018. St. Petersburg; 2018:39–40. (In Russ.). [cited 2021 July 1]. Available from: https://drive.google.com/file/d/16LZb89IA5qXuMINERxZsPh6eGJ584Z11/view
  46. Leone Roberti Maggiore U, Bogani G, Meschia M, et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015;189:48–54. doi: 10.1016/j.ejogrb.2015.03.025
  47. Petros PE, Ulmsten UI. An integral theory and its method for the diagnosis and management of female urinary incontinence. Scand J Urol Nephrol Suppl. 1993;153:1–93.
  48. DeLancey JO, Trowbridge ER, Miller JM, et al. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol. 2008;179(6):2286–2290. doi: 10.1016/j.juro.2008.01.098
  49. Macevoy HJ. Notes on the arrangement and function of the cell groups in the sacral region of the spinal cord. (Journ. Nerv. Ment. Dis., August, 1899.) Onuf, B. Journal of Mental Science. 1900;46(194):563–563. doi: 10.1192/bjp.46.194.563
  50. McGuire EJ, Lytton B, Kohorn EI, Pepe V. The value of urodynamic testing in stress urinary incontinence. J Urol. 1980;124(2):256–258. doi: 10.1016/s0022-5347(17)55396-3
  51. McGuire EJ. Urodynamic findings in patients after failure of stress incontinence operations. Prog Clin Biol Res. 1981;78:351–360.
  52. Kuhn A, Stadlmayr W, Lengsfeld D, Mueller MD. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):817–821. doi: 10.1007/s00192-007-0535-1
  53. Steele AC, Kohli N, Karram MM. Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol. 2000;95(3):327–331. doi: 10.1016/s0029-7844(99)00568-2
  54. Bent AE, Foote J, Siegel S, et al. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol. 2001;166(4):1354–1357. doi: 10.1016/S0022-5347(05)65768-0
  55. Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU Guideline. J Urol. 2017;198(4):875–883. doi: 10.1016/j.juro.2017.06.061
  56. Klinicheskie rekomendacii. Nederzhanie mochi. 2020. Utverzhdeny Minzdravom RF (01.06.2020). (In Russ.). [cited 2021 July 1]. Available from: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf
  57. Koski ME, Enemchukwu EA, Padmanabhan P, et al. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection. Urology. 2011;77(5):1076–1080. doi: 10.1016/j.urology.2010.10.010

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Zhevlakova M., Rusina E., 2021



##common.cookie##